A

Acrivon Therapeutics Inc
NASDAQ:ACRV

Watchlist Manager
Acrivon Therapeutics Inc
NASDAQ:ACRV
Watchlist
Price: 1.83 USD
Market Cap: 57.8m USD

Wall Street
Price Targets

ACRV Price Targets Summary
Acrivon Therapeutics Inc

Wall Street analysts forecast ACRV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACRV is 11.39 USD with a low forecast of 6.06 USD and a high forecast of 19.95 USD.

Lowest
Price Target
6.06 USD
231% Upside
Average
Price Target
11.39 USD
522% Upside
Highest
Price Target
19.95 USD
990% Upside
Acrivon Therapeutics Inc Competitors:
Price Targets
VNDA
Vanda Pharmaceuticals Inc
83% Upside
BONEX
Bonesupport Holding AB
81% Upside
DVAX
Dynavax Technologies Corp
57% Upside
2162
KeyMed Biosciences Inc
41% Upside
IVVD
Invivyd Inc
213% Upside
NGNE
Neurogene Inc
220% Upside
ALKS
Alkermes Plc
46% Upside
ORKA
Oruka Therapeutics Inc
76% Upside

Revenue
Forecast

Revenue Estimate
Acrivon Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Acrivon Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Acrivon Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACRV's stock price target?
Price Target
11.39 USD

According to Wall Street analysts, the average 1-year price target for ACRV is 11.39 USD with a low forecast of 6.06 USD and a high forecast of 19.95 USD.

Back to Top